Economic evaluation of dabigatran, rivaroxaban and warfarin in preventing stroke in patients with atrial fibrillation
CHEN Yong-fa
HAN Hong-na
Keywords：atrial fibrillationstroke preventionnew oral anticoagulantswarfarineconomic evaluation
Publication Date：2016-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)